LASA SUPERGENERICS LTD - Board Meeting Outcome for Revised Outcome Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Rediff Moneywiz

Hi Guest
Feedback

Lasa Supergenerics Ltd - Board Meeting Outcome for Revised Outcome Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Download	< Back
11 Mar 2024
Revised outcome of Board Meeting March 08, 2024 Pursuant to Regulation 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held on March 08, 2024 which was commenced at 2.00 p.m. and concluded at 3.00 p.m. inter- alia have considered and approved the following: 1. Appointment of Mr. Umesh Pawar (DIN: 10539778) as an Additional Director (Executive Director) of the Company and he shall be designated as Whole-time Director of the Company for a term of 5 (five) years with effect from March 08, 2024, subject to the approval of shareholders at General Meeting of the Company.. We are enclosing herewith the brief details of the aforesaid change as prescribed under SEBI Listing Regulations read with SEBI circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, as Annexure I.
View all announcements for Lasa Supergenerics Ltd	Source: BSE India

ALL MONEYWIZ PAGES